MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Pregnancy in Dystonia or Tourette’s patients with DBS. Eleven New Cases and a Review of the Literature.

    R. Mehanna, A. Tarakad, L. Taneff, E. Furr Stimming (Houston, USA)

    Objective: To review the available literature on pregnancy in patients who have received deep brain stimulation (DBS) for dystonia or Tourette’s syndrome (TS). Background: DBS…
  • 2024 International Congress

    Sustained Effect of Posteroventral Pallidotomy for X-Linked Dystonia Parkinsonism

    P. Cataniag, CC. Diesta, JA. Villanueva, JQ. Oropilla (Makati City, Philippines)

    Objective: To determine the effects of Posteroventral Pallidotomy in two patients with X-Linked Dystonia Parkinsonism in the Philippines Background: X-linked dystonia parkinsonism (XDP, DYT3), a disease…
  • 2024 International Congress

    Impact on quality of life and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with essential tremor.

    D. Vilas, L. Ispierto, M. Tardáguila, J. Muñoz, A. González, M. Gea, JA. Pérez, R. García-Yuste, R. álvarez (Badalona, Spain)

    Objective: To describe the impact on quality of life (QoL) and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with refractory…
  • 2024 International Congress

    A Successful Case of Bilateral GPi Rescue DBS in Dystonic Tremor Following Tremor Re-emergence After Previous Bilateral PSA DBS Five Years Prior

    I. Osborne, J. Peters, J. Maamary, Y. Barnett, B. Jonker, S. Tisch (Sydney, Australia)

    Objective: We present a patient with successful rescue bilateral GPi-DBS implantation with sustained clinical benefit to 24 months for management of reemergent severe dystonic tremor…
  • 2024 International Congress

    Cerebral vasoreactivity in patients with Parkinson’s disease and Diabetes Mellitus

    A. Martínez-Rodríguez, M. Cansino-Torres, D. Ortiz-Zacarias, S. Castillo-Torres, F. Góngora-Rivera, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To assess the relationship between loss of CVR and T2DM in patients with Idiopathic PD. Background: The relationship between cerebral vascular disease (CVD) and…
  • 2024 International Congress

    Examination of how DaTscan Impacts Diagnosis in Parkinsonian Patients with and without Dopamine Receptor Blocking Agent Exposure

    R. Lopez-Castellanos, S. Factor, R. Blakes (Atlanta, USA)

    Objective: To determine whether Dopamine transporter imaging impacts diagnosis in parkinsonian patients Background: Dopamine transporter imaging (DaTscan) is a diagnostic tool used to assess loss…
  • 2024 International Congress

    The Contribution of APOE4 Genotype on Structural MRI in Parkinson’s Disease: A Study from the PPMI Cohort

    A. Rosal, A. Strafella, S. Martin (Toronto, Canada)

    Objective: To assess the contribution of Apolipoprotein E4 (APOE4) in Parkinson’s Disease (PD)-related cognitive impairment by analyzing its impact on Gray Matter Volume (GMV). Background:…
  • 2024 International Congress

    Neuroimaging Factors Differentially Associated with Pathology and Clinical Presentation

    J. Pommy, S. Bouchachi, A. Bryant, V. Thornton, C. Nguyen, J. Truelove, K. Rawson, J. Icehour, M. Knopp, C. Wright, D. Scharre (Columbus, USA)

    Objective: Examine utility of a factor analysis approach to neuroimaging data in Lewy body disease (LBD) and Alzheimer’s disease (AD). Background: Significant heterogeneity exists among patients…
  • 2024 International Congress

    Comparing the Selected Device-Aided Therapy of Movement Disorder Specialist Team with Patient Selections

    A. de Leon, O. Phokeawvarangkul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This study aims to compare the decision made by patients and physicians in selecting device-aided therapy (DAT) for advanced Parkinson’s disease (aPD) and to…
  • 2024 International Congress

    Quality of life assessment in patients with Parkinson’s disease

    S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The objective of the study was to assess the quality of life in patients with Parkinson's disease (PD) and to establish statistical correlations with…
  • « Previous Page
  • 1
  • …
  • 438
  • 439
  • 440
  • 441
  • 442
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley